QHY Bioengineering Co., Ltd. is one of the leading manufacturers and suppliers of survodutide peptide in China. We are committed to providing high quality customized products with competitive price. If you're going to wholesale bulk durable survodutide peptide, welcome to get quotation and free sample from our factory.
Product Description
Survodutide peptide is a dual GLP-1 / glucagon receptor agonist peptide. Unlike tirzepatide, survodutide peptide combines GLP-1 receptor agonism with glucagon receptor activation, specifically targeting liver fat metabolism and energy expenditure. It has shown significant potential in research for obesity and MASH (metabolic dysfunction-associated steatohepatitis).
|
Product Name |
Survodutide peptide |
|
Type |
Vials/Powder/or Customizable |
|
MOQ |
1 box |
|
Shelf life |
between 2-3 years |
|
Storage |
Cool and dry, away from sunlight |
|
Package size |
30*30*35cm/50pcs or customers' requirement |
|
Payment method |
USDT, Alipay, Bank Transfer, Bitcoin |
|
Packaging Options |
Blister packs or customers' requirement |
|
Shipping |
DHL , Fedex , UPS , EMS , By air |
|
Delivery Time |
10-15 days after order is confirmed |
Product Applications
1.Metabolic research field
It is a dual-receptor peptide research tool. It is widely used in pre-clinical experiments for weight regulation, energy expenditure and lipid metabolism, suitable for obesity-related research programs.
2.Liver-related mechanism research
Featuring GLP-1R and GCGR dual activation, survodutide peptide supports hepatic lipid metabolism research. It is used to explore pathological mechanisms of fatty liver and MASH for liver-metabolism experimental models.
3.Glucose metabolism & diabetes research
It applies to laboratory studies on glucose-dependent insulin secretion. It is used in type 2 diabetes model experiments to observe changes of fasting and post-prandial blood glucose.
FAQ
Q1: What is Survodutide peptide?
A: It is a long acting dual agonist peptide. It activates both GLP 1 receptor and glucagon receptor (GCGR). It is an investigational compound under Phase 3 clinical trials for metabolic related research.
Q2: What are its core advantages?
A: Beyond appetite suppression, the glucagon‑receptor pathway enhances energy consumption and directly targets liver fat reduction.
Q3: How long does it take to see results with Survodutide?
A: In clinical trials, significant reductions in liver fat and body weight are typically observed within the first 16 to 24 weeks of treatment. In Phase II studies, weight loss peaked at approximately 46 weeks of treatment.
Q4: About Shipping and Packaging
A: The lyophilized peptides are shipped with insulated packaging consisting of carton boxes and foam inserts, to guarantee product stability during international transit.
Hot Tags: survodutide peptide, China survodutide peptide
